×
Past month
  • Any time
  • Past hour
  • Past 24 hours
  • Past week
  • Past month
  • Past year
All results
Apr 30, 2024 · A phase-2 trial combining oral temozolomide with intravenous SGT-53 (P53 gene therapy) sponsored by SynerGene Therapeutics is being conducted to treat recurrent ...